Nurse Practitioner, Acute Care · Little Rock, AR
NPI
1619918505
Since 2006
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
500 S University Ave Ste 316
Little Rock, AR, 72205
Phone (501) 261-6450
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
746 services
Medicare patients, 2024
224
Average age 67
Drug cost, 2024
$3.7M
2,248 prescriptions
Company payments, 2025
$32K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lynn M Frazier was code 99439 (chronic, principal, and transitional care management), 263 times for 70 patients. In total Lynn M Frazier billed 746 services in 16 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 263 | 70 | $31.25 | $8,220 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 165 | 71 | $40.83 | $6,737 |
| 99213 Office E&M - Established | Office | 130 | 116 | $58.52 | $7,608 |
| 91200 Standard X-ray | Office | 42 | 41 | $19.28 | $810 |
| 99203 Office E&M - New | Office | 35 | 35 | $70.82 | $2,479 |
| 99212 Office E&M - Established | Office | 28 | 27 | $35.90 | $1,005 |
| 93975 Duplex Scan - Extremity Arteries | Office | 18 | 18 | $164.35 | $2,958 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 11 | 11 | $73.30 | $806 |
Medicare prescription drug claims, 2024
In 2024, the drug Lynn M Frazier prescribed most often to Medicare patients was Xifaxan (Rifaximin), with 215 prescriptions and refills. In total Lynn M Frazier wrote 2,248 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xifaxan Rifaximin | 215 | 215 | 41 | $694K |
| Spironolactone Generic | 153 | 256 | 39 | $1,630 |
| Ursodiol Generic | 149 | 187 | 29 | $21K |
| Omeprazole Generic | 139 | 285 | 62 | $3,402 |
| Lactulose Generic | 136 | 160 | 40 | $4,202 |
| Furosemide Generic | 105 | 152 | 31 | $358 |
| Tenofovir Disoproxil Fumarate Generic | 64 | 79 | Under 11 | $7,556 |
| Rezdiffra Resmetirom | 63 | 63 | 13 | $247K |
| Epclusa Sofosbuvir/Velpatasvir | 59 | 59 | 27 | $1.4M |
| Famotidine Generic | 58 | 113 | 26 | $1,302 |
| Bumetanide Generic | 57 | 79 | 13 | $1,197 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 55 | 55 | Under 11 | $222K |
| Vemlidy Tenofovir Alafenamide | 44 | 46 | Under 11 | $69K |
| Rosuvastatin Calcium Generic | 43 | 68 | Under 11 | $219 |
| Pantoprazole Sodium Generic | 42 | 86 | 19 | $666 |
Brand drugs: - claims; generic drugs: 1,624 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lynn M Frazier $32K ($32K in general payments such as food, travel and fees) from 13 companies. The largest payer was Ipsen Biopharmaceuticals, Inc with $15K.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc IPN.PA | 27 | $15K |
| Madrigal Pharmaceuticals MDGL | 31 | $9,128 |
| Gilead Sciences, Inc. GILD | 30 | $6,565 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $195 |
| ViiV Healthcare Company GSK | 17 | $176 |
| Mirum Pharmaceuticals, Inc. MIRM | 1 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $118 |
| Novo Nordisk Inc NVO | 5 | $106 |
| Abbvie Inc. ABBV | 4 | $94 |
| Xeris Pharmaceuticals, Inc. | 2 | $40.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.